| Denumire comercială | DCI | Forma farmaceutică | Cod ATC | Cod CIM | Firma / țara deținătoare APP |  |
 |
 |
 |
 |
|
|---|---|---|---|---|---|---|---|---|---|---|---|
| METRONIDAZOL VIOSER 500 mg/100 ml | METRONIDAZOLUM | SOL. PERF. | J01XD01 | W64585001 | VIOSER S.A. PARENTERAL SOLUTIONS INDUSTRY - GRECIA | ||||||
| METRONIDAZOL VIOSER 500 mg/100 ml | METRONIDAZOLUM | SOL. PERF. | J01XD01 | W64585002 | VIOSER S.A. PARENTERAL SOLUTIONS INDUSTRY - GRECIA | ||||||
| MOFLAXA 400 mg/250 ml | MOXIFLOXACINUM | SOL. PERF. | J01MA14 | W62717001 | KRKA, D.D., NOVO MESTO - SLOVENIA | ||||||
| MOFLAXA 400 mg/250 ml | MOXIFLOXACINUM | SOL. PERF. | J01MA14 | W62717002 | KRKA, D.D., NOVO MESTO - SLOVENIA | ||||||
| MOFLAXA 400 mg/250 ml | MOXIFLOXACINUM | SOL. PERF. | J01MA14 | W62717003 | KRKA, D.D., NOVO MESTO - SLOVENIA | ||||||
| MOXIFLOXACINA KABI 400 mg/250 ml | MOXIFLOXACINUM | SOL. PERF. | J01MA14 | W60727001 | FRESENIUS KABI ROMANIA S.R.L. - ROMANIA | ||||||
| MOXIFLOXACINA KABI 400 mg/250 ml | MOXIFLOXACINUM | SOL. PERF. | J01MA14 | W60727002 | FRESENIUS KABI ROMANIA S.R.L. - ROMANIA | ||||||
| MOXIFLOXACINA KABI 400 mg/250 ml | MOXIFLOXACINUM | SOL. PERF. | J01MA14 | W60727003 | FRESENIUS KABI ROMANIA S.R.L. - ROMANIA | ||||||
| MOXIFLOXACINA KABI 400 mg/250 ml | MOXIFLOXACINUM | SOL. PERF. | J01MA14 | W60727004 | FRESENIUS KABI ROMANIA S.R.L. - ROMANIA | ||||||
| MOXIFLOXACINA KABI 400 mg/250 ml | MOXIFLOXACINUM | SOL. PERF. | J01MA14 | W60727005 | FRESENIUS KABI ROMANIA S.R.L. - ROMANIA | ||||||
| MOXIFLOXACINA KABI 400 mg/250 ml | MOXIFLOXACINUM | SOL. PERF. | J01MA14 | W60727006 | FRESENIUS KABI ROMANIA S.R.L. - ROMANIA | ||||||
| MOXIFLOXACINA KABI 400 mg/250 ml | MOXIFLOXACINUM | SOL. PERF. | J01MA14 | W60727007 | FRESENIUS KABI ROMANIA S.R.L. - ROMANIA | ||||||
| MOXIFLOXACINA KABI 400 mg/250 ml | MOXIFLOXACINUM | SOL. PERF. | J01MA14 | W60727008 | FRESENIUS KABI ROMANIA S.R.L. - ROMANIA | ||||||
| MOXIFLOXACINA KABI 400 mg/250 ml | MOXIFLOXACINUM | SOL. PERF. | J01MA14 | W60727009 | FRESENIUS KABI ROMANIA S.R.L. - ROMANIA | ||||||
| MOXIFLOXACINA KABI 400 mg/250 ml | MOXIFLOXACINUM | SOL. PERF. | J01MA14 | W60727010 | FRESENIUS KABI ROMANIA S.R.L. - ROMANIA | ||||||
| MOXIFLOXACINA ROMPHARM 400 mg/250 ml | MOXIFLOXACINUM | SOL. PERF. | J01MA14 | W63849001 | ROMPHARM COMPANY S.R.L. - ROMANIA | ||||||
| MOXIFLOXACINA ROMPHARM 400 mg/250 ml | MOXIFLOXACINUM | SOL. PERF. | J01MA14 | W63849002 | ROMPHARM COMPANY S.R.L. - ROMANIA | ||||||
| NEODOLPASSE 0,30 mg+0,12 mg/ml | COMBINATII (DICLOFENACUM+ORPHENADRINUM CITRAS) | SOL. PERF. | M01AB55 | W64231001 | FRESENIUS KABI ROMANIA S.R.L. - ROMANIA | ||||||
| NEODOLPASSE 0,30 mg+0,12 mg/ml | COMBINATII (DICLOFENACUM+ORPHENADRINUM CITRAS) | SOL. PERF. | M01AB55 | W64231002 | FRESENIUS KABI ROMANIA S.R.L. - ROMANIA | ||||||
| NEODOLPASSE 0,30 mg+0,12 mg/ml | COMBINATII (DICLOFENACUM+ORPHENADRINUM CITRAS) | SOL. PERF. | M01AB55 | W64231003 | FRESENIUS KABI ROMANIA S.R.L. - ROMANIA |
ANMDMR - Nomenclatorul medicamentelor pentru uz uman